Finland· FI-REL-REL669

Zegam

A sparfloxacin product containing sparfloxacin, registered in Finland by Rhone Dpc Europe.

ATC J01MA09

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedZegamATCJ01MA09REGISTER NO.FI-REL-REL669PACKS LISTED0CHECKEDSeptember 27, 2026

The record

At a glance

Fimea (Finland)
Active substance
Sparfloxacin
Manufacturer
Rhone Dpc Europe
Country
Finland (FI)
ATC code
J01MA09
ATC class
Sparfloxacin
Defined daily dose
0.2 g, O
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

328 interactions on record for sparfloxacin.

Graded by severity as the source publishes them — 163 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Sparfloxacin · interactions on record

328 records

  • 163 severe
  • 115 moderate
  • 50 minor

Most severe, free to view

  • PapaverineA03AD01severe
  • OndansetronA04AA01severe
  • GranisetronA04AA02severe
  • DolasetronA04AA04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under J01MA09

Sparfloxacin, as other registers publish it.

All sparfloxacin products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/50c3ac8b-fa24-4996-b348-543082cb625e
GET /v1/drugs/50c3ac8b-fa24-4996-b348-543082cb625e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "0.2",
  "form": "tabletti",
  "route": null,
  "ddd_unit": "g",
  "strength": "200 mg",
  "atc_label": "sparfloksasiini",
  "ma_number": "11808",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL669",
  "authorised_at": "1995-03-20"
}

See everything about sparfloxacin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.